BISPECIFIC ANTIBODIES DIRECTED TO CD3AND HBSAG TO TREAT CHRONIC HEPATITIS B VIRUS
Federal financial assistance recorded from USAspending. This is not a procurement contract.
Research this with AI
Research smarter with AI
Analyze opportunities and compare insights across leading AI models.
ASST_NON_R43AI148053_075 · TENEOBIO, INC. · Department of Health and Human Services
Compare Multiple AI Models with SmartSoloExplore CaptureIQ IntelligenceAssistance award details
- Assistance award identifier
- ASST_NON_R43AI148053_075
- FAIN
- R43AI148053
- Recipient
- TENEOBIO, INC.
- Awarding agency
- Department of Health and Human Services
- Funding agency
- Department of Health and Human Services
- Assistance listing (CFDA)
- 93.855
- Total obligated
- $269,063
- Period
- Jul 24, 2019 – Jun 30, 2020
- Fiscal year
- 2019
- Place of performance state
- CA
- Source file
- FY2019_All_Assistance_Full_20261006.zip
Description
BISPECIFIC ANTIBODIES DIRECTED TO CD3AND HBSAG TO TREAT CHRONIC HEPATITIS B VIRUS